S&P 500 (NYSE:SPY) component AmerisourceBergen Corp. (NYSE:ABC) will unveil its latest earnings on Thursday, July 28, 2011. AmerisourceBergen Corporation is a pharmaceutical services company providing drug distribution and related healthcare services to pharmacy, physician, and manufacturer customers based in North America.
AmerisourceBergen Corp. Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for profit of 59 cents per share, a rise of 13.5% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from 58 cents. For the year, analysts are projecting net income of $2.49 per share, a rise of 15.3% from last year.
Past Earnings Performance: The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 8 cents, reporting profit of 77 cents per share against a mean estimate of net income of 69 cents per share.
Wall St. Revenue Expectations: On average, analysts predict $20.17 billion in revenue this quarter, a rise of 2.9% from the year ago quarter. Analysts are forecasting total revenue of $80 billion for the year, a rise of 2.6% from last year’s revenue of $77.95 billion.
Analyst Ratings: Analysts are bullish on this stock with 13 analysts rating it as a buy, none rating it as a sell and four rating it as a hold.
The company has now seen net income rise in three straight quarters. In the second quarter, net income rose 18.4% while it rose 6.1% in the first quarter and 8.5% in the fourth quarter of the last fiscal year.
Revenue has risen the past four quarters. Revenue increased 2.4% to $19.76 billion in second quarter. The figure rose 2.9% in the first quarter from the year earlier, climbed 5.3% in the fourth quarter of the last fiscal year from the year-ago quarter and 6.6% in the third quarter of the last fiscal year.
Competitors to Watch: McKesson Corporation (NYSE:MCK), Cardinal Health, Inc. (NYSE:CAH), Henry Schein, Inc. (NASDAQ:HSIC), Omnicare, Inc. (NYSE:OCR), BioScrip Inc. (NASDAQ:BIOS), Grupo Casa Saba, S.A. (NYSE:SAB), Owens & Minor, Inc. (NYSE:OMI), Patterson Companies, Inc. (NASDAQ:PDCO), PSS World Medical, Inc. (NASDAQ:PSSI), and MWI Veterinary Supply, Inc. (NASDAQ:MWIV).
Stock Price Performance: During April 27, 2011 to July 22, 2011, the stock price had fallen $1.39 (-3.3%) from $41.91 to $40.52. The stock price saw one of its best stretches over the last year between December 13, 2010 and December 23, 2010 when shares rose for nine-straight days, rising 9.5% (+$2.96) over that span. It saw one of its worst periods between November 22, 2010 and November 30, 2010 when shares fell for six-straight days, falling 0.8% (-26 cents) over that span. Shares are up $6.59 (+19.4%) year to date.
(Source: Xignite Financials)